Research resources drug supply program catalog

Abstract

The Drug Supply Program facilitates basic and clinical research by providing standardized drugs of abuse, metabolites, and related ligands to qualified investigators. Available materials encompass a broad range of pharmacological categories, including stimulants, hallucinogens, narcotics, cannabinoids, and opioid peptides. The inventory further includes radiolabeled and deuterium-labeled compounds to support specialized tracing and analytical studies. Access to these resources requires the submission of detailed research protocols for scientific review, ensuring compatibility with public health research goals. Regulatory compliance is mandated via the verification of Drug Enforcement Administration (DEA) registrations and, where applicable, Food and Drug Administration (FDA) approvals for clinical studies. Beyond the provision of chemical substances, the program offers essential analytical services, including X-ray diffraction for definitive three-dimensional structural characterization and the quantitative analysis of experimental biological specimens through specialized contract laboratories. These integrated resources are designed to standardize the materials used in neuroscientific and behavioral research, thereby enhancing the reproducibility and rigor of investigations into the physiological and chemical properties of controlled substances. – AI-generated abstract.